Search Icon
SideMenu
Home
Reports

Biosimilars Council Press Releases

Reports
  • Reports

White Paper: Potential Savings from Accelerating U.S. Approval of Complex Generics
  • Reports

White Paper: Access Denied: Why New Generics Are Not Reaching America’s Seniors
  • Reports

The Unintended Economics of the BLOCKING Act
  • Reports

Medicare Part D Generic Drug Tiering Request for Comment: Implications for Patient Out-of-Pocket Spending and Part D Plan Costs
  • Reports

7 Policy Solutions
  • Reports

Report: 2019 Generic Drug & Biosimilars Access & Savings in the U.S.
  • Reports

2020 Generic Drug & Biosimilars Access and Savings in the U.S. Report
  • Reports

The USMCA Will Keep Drug Prices Out of Reach for Patients, But Congress Can Fix It
  • Reports

Biosimilars Handbook
  • Reports

Commitment to Quality Excellence
  • Reports

White Paper (Part 1) Failure to Launch: Patent Abuse Blocks Access to Biosimilars for America’s Patients
  • Reports

2018 Generic Drug Access and Savings Report
Load More